相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis
Baris Gungor et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019 A Systematic Review and Meta-analysis
David Jimenez et al.
CHEST (2021)
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker et al.
BLOOD ADVANCES (2021)
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial
Parham Sadeghipour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial
Renato D. Lopes et al.
AMERICAN HEART JOURNAL (2021)
Coagulopathy of Coronavirus Disease 2019
Toshiaki Iba et al.
CRITICAL CARE MEDICINE (2020)
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Alex C. Spyropoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019 CHEST Guideline and Expert Panel Report
Lisa K. Moores et al.
CHEST (2020)
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hanny Al-Samkari et al.
BLOOD (2020)
Postdischarge venous thromboembolism following hospital admission with COVID-19
Lara N. Roberts et al.
BLOOD (2020)
Randomized Trials Versus Common Sense and Clinical Observation JACC Review Topic of the Week
Alexander C. Fanaroff et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Alex C. Spyropoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
A. B. Cavalcanti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Anticoagulation in COVID-19 It Is Time for High-Quality Evidence
Renato D. Lopes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Girish N. Nadkarni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
Baranca Buijsers et al.
EBIOMEDICINE (2020)
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Helio P. Guimaraes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The stratified win ratio
Gaohong Dong et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2018)
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
Alex C. Spyropoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
Stuart J. Pocock et al.
EUROPEAN HEART JOURNAL (2012)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)